By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cellectar Biosciences (Formerly Known As Novelos Therapeutics, Inc.)  

3301 Agriculture Drive

Madison  Wisconsin  53716  U.S.A.
Phone: 608-441-8120 Fax: 608-441-8120


Key Statistics

Ownership: Public

Web Site: Cellectar Biosciences
Symbol: CLRB


Drug Discovery

Company News
Three Abstracts On Dosing Regimens Of Cellectar Biosciences  (CLRB)’s CLR 131 In A Variety Of Tumor Types Published In The 2017 ASCO Annual Meeting Proceedings 5/18/2017 10:18:24 AM
Cellectar Biosciences  (CLRB) Reports First Quarter 2017 Financial and Corporate Performance 5/12/2017 12:35:11 PM
Cellectar Biosciences  (CLRB) To Host Conference Call On May 11, 2017 To Report First Quarter 2017 Financial Results And Corporate Performance 5/2/2017 10:26:21 AM
Cellectar Biosciences  (CLRB)’s Radiotherapeutic Pdcs Demonstrate An Increased Survival Benefit Using Multiple Doses In Preclinical Studies 4/27/2017 8:54:03 AM
Cellectar Biosciences  (CLRB) Receives Additional U.S. Patents For PDC Optical Agents In The Detection Of Multiple Cancers 4/25/2017 8:33:13 AM
Cellectar Biosciences  (CLRB) Receives Japanese Patent For CLR 131 And CLR 125 For The Treatment Of Cancer Stem Cells 4/18/2017 8:49:29 AM
Cellectar Biosciences  (CLRB) Strengthens Management Team With Appointment Of John Friend, M.D. As Chief Medical Officer 4/13/2017 10:04:28 AM
Cellectar Biosciences  (CLRB) Adds Industry Veterans Douglas Swirsky And Frederick Driscoll To Its Board Of Directors 4/11/2017 10:30:11 AM
After Much Anticipation, Cellectar Biosciences  (CLRB) Initiates NCI-Supported Phase II Trial Of CLR 131 In Multiple Myeloma And Other Blood Cancers 3/30/2017 8:12:16 AM
Cellectar Biosciences  (CLRB) Further Deepens Intellectual Property Portfolio With Patent Grant For PET Imaging PDC 3/21/2017 10:44:35 AM